In the centrally-located osteosarcomas (spine or ileum), 5/6 (83%) were positive for bcl-2, whereas only 16/43 (37%) of the peripheral osteosarcomas of the long bones were positive (Table I). Here, BCL2 is linked to osteosarcoma.